Introduction: Paving the Way for Biomedical HIV Prevention Interventions in Youth
Authors:
- Bill G KapogiannisBKBill G Kapogiannis
- Ed HandelsmanEHEd Handelsman
- Monica S RuizMRMonica S Ruiz
- Sonia LeeSLSonia Lee
- 1 July 2010
- journal article
- other
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 54 (Supplement) , S1-S4
Abstract
The HIV epidemic among youth continues to grow at alarming proportions throughout the world. Efficacious and comprehensive biomedical prevention interventions are desperately needed for this vulnerable population if a reduction in global HIV incidence is to be achieved. To succeed at enrolling youth in studies of such modalities, communities whose youth will be participating must be highly engaged throughout the spectrum of research concept development to implementation and later translation into programs. In this process, there are numerous challenges, both intrinsic and extrinsic to the youth themselves. Intrinsic ones include developmental considerations in physiology, pharmacology, and behavior; extrinsic considerations are those in the community, ethical, legal, and regulatory arenas and those in designing clinical trials for youth to feasibly participate. We convened a consultative meeting to deliberate over these considerations among a variety of experts representing youth and their community, advocacy groups, academia, industry, regulators, and others in the federal government. Broad recommendations aimed at many stakeholders in the adolescent HIV prevention research agenda were made and were to improve the timely inclusion of youth in this research to ensure that prevention agents can be used safely by youth as soon as they become available to adults.Keywords
This publication has 16 references indexed in Scilit:
- Mobilizing Communities Around HIV Prevention for Youth: How Three Coalitions Applied Key Strategies to Bring About Structural ChangesAIDS Education and Prevention, 2010
- Adolescents in Clinical TrialsClinical Pharmacology & Therapeutics, 2008
- Estimation of HIV Incidence in the United StatesJAMA, 2008
- Pharmacokinetics of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate and Atazanavir-Ritonavir in Adolescents and Young Adults with Human Immunodeficiency Virus InfectionAntimicrobial Agents and Chemotherapy, 2008
- Use of Geographic Information Systems for Planning HIV Prevention Interventions for High-Risk YouthsAmerican Journal of Public Health, 2007
- Adolescents and HIV infectionCurrent Opinion in HIV and AIDS, 2007
- Enrolling Adolescents in Research on HIV and Other Sensitive Issues: Lessons from South AfricaPLOS Medicine, 2006
- Laying the Foundation for Connect to Protect ®: A Multi-Site Community Mobilization Intervention to Reduce HIV/AIDS Incidence and Prevalence among Urban YouthJournal of Urban Health, 2006
- Evaluation of Child/Adult Pharmacokinetic Differences from a Database Derived from the Therapeutic Drug LiteratureToxicological Sciences, 2002
- Introduction to the special issue on pharmacokinetics and pharmacodynamics in adolescentsJournal of Adolescent Health, 1994